文献速递类风湿关节炎

抗氨甲酰化蛋白抗体稳定氨甲酰化组蛋白H3促进类风湿关节炎滑膜活化及中性粒细胞胞外诱捕网介导的骨丢失

Anti-Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap-Mediated Bone Loss in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2026-04-16

该研究探讨氨甲酰化及抗氨甲酰化蛋白抗体(anti-CarP)促进关节病理的机制。研究发现中性粒细胞胞外诱捕网(NETs)形成过程中组蛋白H3发生氨甲酰化,anti-CarP抗体可保护氨甲酰化H3免受中性粒细胞弹性蛋白酶降解,增强TLR4活化和破骨细胞生成,并诱导成纤维样滑膜细胞炎症因子分泌。

要点

  • NETs是氨甲酰化自身抗原的主要来源,H3氨甲酰化不依赖PAD4、MPO、NE或氧化途径。
  • anti-CarP抗体保护氨甲酰化H3免受NE降解,增强TLR4活化和破骨细胞生成。
  • 氨甲酰化H3-IgG免疫复合物强烈激活FLS,诱导IL-6、IL-8、MCP-1、GM-CSF分泌。

核心结论

  • anti-CarP抗体稳定NETs中的氨甲酰化H3,放大其促炎和促破骨活性。
  • 形成的氨甲酰化H3-IgG免疫复合物有效激活FLS,连接体液免疫与RA组织炎症和骨破坏。
  • 氨甲酰化H3稳定化是抗体介导关节损伤的潜在治疗靶点。

研究设计与样本

  • 基础实验研究:用钙离子载体生成NETs,通过免疫荧光、流式细胞术和质谱分析氨甲酰化。
  • 使用药理学抑制剂和PAD2/4缺陷小鼠探究酶学途径。
  • 用中性粒细胞弹性蛋白酶和RA患者anti-CarP IgG评估氨甲酰化H3降解动力学。
  • 用HEK293报告细胞系定量TLR4活化,用RNA测序和ELISA分析RA FLS对氨甲酰化H3或免疫复合物的反应。

主要发现

  • NETosis过程中组蛋白氨甲酰化(尤其H3)发生,不依赖PAD4、MPO、NE或氧化途径。
  • 氨甲酰化H3可被NE快速降解,但anti-CarP抗体保护其免受蛋白水解。
  • 暴露于anti-CarP IgG的NETs触发更强的TLR4活化和增强的破骨细胞生成。
  • 在FLS中,氨甲酰化H3尤其氨甲酰化H3-免疫复合物诱导促炎基因上调和细胞因子分泌(IL-6、IL-8、MCP-1、GM-CSF)。
  • 转录组分析显示免疫激活、趋化和血管生成通路富集,以氨甲酰化H3-免疫复合物最为显著。

关键数值与推荐

  • anti-CarP存在于约50%的RA患者中,并与更严重的关节损伤相关。

临床怎么用

  • 提示anti-CarP抗体不仅作为标志物,还通过稳定氨甲酰化H3主动参与RA关节炎症和骨破坏。
  • 氨甲酰化H3稳定化可能成为抗体介导关节损伤的潜在治疗靶点。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Carbamylation, a nonenzymatic post-translational modification, contributes to rheumatoid arthritis (RA) pathogenesis. Anti-carbamylated protein antibodies (anti-CarP) occur in around 50% of patients with RA and associate with greater joint damage. Neutrophil extracellular traps (NETs) are a major source of carbamylated autoantigens. We sought to study how carbamylation and anti-CarP antibodies promote joint pathology. METHODS: NETs were generated with calcium ionophore and analyzed for carbamylation by immunofluorescence, flow cytometry, and mass spectrometry. Enzymatic pathways were interrogated using pharmacologic inhibitors and peptidyl arginine deiminase (PAD)2/4 deficient mice. Degradation kinetics of carbamylated histone H3 (carH3) were evaluated with neutrophil elastase (NE) and anti-CarP IgG from patients with RA. Toll-like receptor 4 (TLR4) activation was quantified using a HEK293 reporter line. RA fibroblast-like synoviocytes (FLS) were stimulated with carH3 or carH3-IgG immune complexes (ICs) and profiled by RNA-sequencing and enzyme-linked immunosorbent assay. RESULTS: Histone carbamylation, especially of H3, occurred during NETosis and was independent of peptidylarginine deiminase-4, myeloperoxidase, NE, or oxidative pathways. CarH3 was rapidly degraded by NE, but anti-CarP antibodies protected it from proteolysis. NETs exposed to anti-CarP IgG triggered stronger TLR4 activation and enhanced osteoclastogenesis. In FLS, carH3 and particularly carH3-ICs induced robust up-regulation of pro-inflammatory genes and cytokine secretion (interleukin [IL-]6, IL-8, MCP-1, GM-CSF). Transcriptomic analysis revealed enrichment of immune activation, chemotaxis, and angiogenesis pathways, most pronounced with carH3-IC. CONCLUSION: Anti-CarP antibodies stabilize carH3 within NETs, amplifying its pro-inflammatory and osteoclastogenic activity. The resulting carH3-IgG ICs potently activate FLS, linking humoral immunity to tissue inflammation and bone destruction in RA. These findings identify carH3 stabilization as a potential therapeutic target in antibody-mediated joint damage.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Nakabo S, Hanata N, Patino-Martinez E, et al. Anti-Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap-Mediated Bone Loss in Rheumatoid Arthritis. Arthritis Rheumatol. 2026. PMID: 41930627. doi:10.1002/art.70158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。